Dietary glycine protects from chemotherapy-induced hepatotoxicity

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

(2009) B. Nordlinger et al.   ANNALS OF ONCOLOGY

Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases

(2009) Gianluca Masi et al.   ANNALS OF SURGERY

Chemotherapy prior to Hepatic Resection for Colorectal Liver Metastases: Helpful until Harmful?

(2009) Eddie K. Abdalla et al.   DIGESTIVE SURGERY

Surgery after neoadjuvant chemotherapy for colorectal liver metastases is safe and feasible in elderly patients

(2009) Dietmar Tamandl et al.   JOURNAL OF SURGICAL ONCOLOGY

Recurrent disease four years after surgery and adjuvant chemotherapy

(2008) Carmelo Pozzo et al.   CANCER TREATMENT REVIEWS

Advances in neoadjuvant therapy for colorectal cancer with liver metastases

(2008) Carmelo Pozzo et al.   CANCER TREATMENT REVIEWS

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET

Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases

(2007) G. Morris-Stiff et al.   EJSO

Donor Preconditioning with Taurine Protects Kidney Grafts from Injury After Experimental Transplantation

(2007) Xiaohai Guan et al.   JOURNAL OF SURGICAL RESEARCH